Written question asked by Lord Mendelsohn (Labour) on Wednesday, 15 March 2023, in the House of Lords. It was due for an answer on Wednesday, 29 March 2023. It was answered by Lord Markham (Conservative) on Thursday, 30 March 2023 on behalf of the Department of Health and Social Care.

Coronavirus: Medical Treatments

Question: To ask His Majesty's Government, further to the Written Answers by Lord Markham on 2 February (HL4910), 8 February (HL4944) and 7 March (HL5695 and HL5938), why the Therapeutics Clinical Review Panel (TCRP) did not review the report Qcovid 4 - Predicting risk of death or hospitalisation from COVID-19, published in August 2022, when it met in January; why this report was not provided by the TCRP to the National Institute for Clinical Excellence; and when the TCRP will meet to review this report.

Answer: The Therapeutics Clinical Review Panel met on 31 January 2023 to review the most recent evidence on COVID-19 risk, including QCovid 4. The evidence considered by the Panel was shared with the National Institute for Health and Care Excellence (NICE). The report entitled QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 is also in the public domain in an online-only format and available to NICE.

Secondary information

Type: Written question
Reference: HL6528
Session: 2022-23
Related items: Coronavirus: Immunosuppression
Thursday, 2 February 2023
Written questions
House of Lords; Tixagevimab/cilgavimab
Wednesday, 8 February 2023
Written questions
House of Lords; Tixagevimab/cilgavimab
Tuesday, 7 March 2023
Written questions
House of Lords; Coronavirus: Immunosuppression
Tuesday, 7 March 2023
Written questions
House of Lords
Subjects: Medical treatments Coronavirus
Link: View this Written question on www.parliament.uk